1162837

The Procter & Gamble Manufacturing Company — FEI 1033800

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 18, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Browns Summit, NC (United States)

Citations

IDCFRDescription
202821 CFR 211.192Extent of discrepancy, failure investigations
358521 CFR 211.110(a)Control procedures to monitor and validate performance
430321 CFR 211.67(b)Written procedures fail to include